SCHEMBL19626495

SCHEMBL19626495

Cc1nc(-c2ccc(N3CCCC3)c(Br)c2)cs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
TRIM24 O15164 1/20 0.51
RAB9A P51151 6/20 0.49
ALDH1A1 P00352 5/20 0.49
NPC1 O15118 4/20 0.49
PKM P14618 1/20 0.49
NPSR1 Q6W5P4 2/20 0.48
TSHR P16473 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 3/20 0.48
GAA P10253 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
ESR2 Q92731 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
HSD17B10 Q99714 1/20 0.47
CASP3 P42574 1/20 0.46
CASP2 P42575 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625373 0.86 RAB9A (0.44) MAPTTRIM24RAB9AALDH1A1NPC1
SCHEMBL19626789 0.83 ALDH1A1 (0.50) MAPTTRIM24RAB9AALDH1A1NPC1
SCHEMBL19626597 0.81 TRIM24 (0.48) MAPTTRIM24RAB9AALDH1A1NPC1
SCHEMBL19626779 0.80 ALDH1A1 (0.47) MAPTTRIM24RAB9AALDH1A1NPC1
SCHEMBL7040245 0.77 RAB9A (0.59) MAPTRAB9AALDH1A1NPC1PKM
SCHEMBL19626520 0.76 ALDH1A1 (0.44) MAPTTRIM24RAB9AALDH1A1NPC1
Bromide SCHEMBL6832825 0.76 RAB9A (0.58) MAPTTRIM24RAB9AALDH1A1NPC1
SCHEMBL19627013 0.76 RAB9A (0.60) MAPTRAB9AALDH1A1NPC1PKM
SCHEMBL17626007 0.75 MAPT (0.41) MAPTRAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL19627025 0.75 TSHR (0.60) MAPTRAB9AALDH1A1NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 MAPT 4783/4885TRIM24 3531/4885RAB9A 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.